Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Attorney Spotlight: Julia Tamulis

November 6, 2014

Julia TamulisTell us about your practice.

I prepare, file and argue appeals of Medicare reimbursement denials on behalf of hospitals. Recently, I have assisted hospitals in preparing for participation in CMS' settlement program designed to alleviate the tremendous backlog of Medicare appeals, particularly at the ALJ level. Additionally, as part of the firm's healthcare fraud task force, I assist with the process of responding to government healthcare fraud investigations and provide related healthcare regulatory analysis.

What are some trends you are seeing related to the legal industry or in the industry in which you practice?

In the Medicare appeals space, providers are struggling with the practical implications of the massive delays in the appeals system in terms of employee resources and finances. In anticipation of the October 31, 2014 deadline for hospitals with appeals of inpatient status claims to settle with CMS, hospitals are analyzing the volume, strength, and value of such claims against the benefits of settlement. In the healthcare fraud area, the government's recent actions and pronouncements indicate an increased use of non-monetary enforcement tactics, including robust corporate integrity agreements, to encourage industry compliance.

How did your work at HHS prepare you for the work you currently are doing?

While at HHS, I drafted decisions in Medicare appeals under Medicare Part A and B for the Medicare Operations Division of the Departmental Appeals Board, the highest level of administrative review within HHS. This experience gave me a solid introduction to Medicare, requiring me to spend most of my time immersed in the Medicare regulations. Beyond developing my writing skills, my time at HHS afforded me an opportunity to spend all of my working time analyzing healthcare regulations and applying them to different fact scenarios, which has proved an excellent background to both my appeals work and my healthcare fraud investigation work.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.